Tower Research Capital LLC (TRC) - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 49 filers reported holding EVELO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$6
-33.3%
32,327
+507.7%
0.00%
Q4 2022$9
-99.9%
5,320
+0.7%
0.00%
Q3 2022$11,000
-15.4%
5,285
-11.2%
0.00%
Q2 2022$13,000
+30.0%
5,952
+108.3%
0.00%
Q1 2022$10,000
-75.0%
2,858
-57.2%
0.00%
-100.0%
Q4 2021$40,000
+25.0%
6,679
+46.4%
0.00%0.0%
Q3 2021$32,000
-3.0%
4,561
+91.0%
0.00%0.0%
Q2 2021$33,000
+57.1%
2,388
+24.3%
0.00%
Q1 2021$21,000
-48.8%
1,921
-44.0%
0.00%
-100.0%
Q4 2020$41,000
-53.4%
3,429
-79.6%
0.00%0.0%
Q3 2020$88,000
+486.7%
16,783
+459.4%
0.00%0.0%
Q2 2020$15,000
+650.0%
3,000
+408.5%
0.00%
Q1 2020$2,000
-71.4%
590
-65.8%
0.00%
-100.0%
Q4 2019$7,000
-70.8%
1,723
-57.5%
0.00%
-50.0%
Q3 2019$24,000
+2300.0%
4,057
+4170.5%
0.00%
Q2 2019$1,000
-97.4%
95
-98.0%
0.00%
-100.0%
Q1 2019$38,000
+40.7%
4,750
+129.0%
0.00%0.0%
Q4 2018$27,000
-43.8%
2,074
-47.2%
0.00%
-50.0%
Q3 2018$48,000
+140.0%
3,931
+128.8%
0.00%
+300.0%
Q2 2018$20,0001,7180.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Mayo Clinic 479,242$6,585,0007.28%
Flagship Pioneering Inc. 23,030,069$316,433,0004.04%
HARBOURVEST PARTNERS LLC 3,063,505$42,093,0004.02%
Trustees of Columbia University in the City of New York 113,850$1,564,0002.31%
Alphabet Inc. 1,060,495$14,571,0000.30%
Artal Group S.A. 1,000,000$13,740,0000.28%
Larson Financial Group LLC 31,354$431,0000.10%
Virtus ETF Advisers LLC 13,690$188,0000.08%
STATE OF MICHIGAN RETIREMENT SYSTEM 900,000$12,366,0000.07%
CREDIT SUISSE AG/ 3,095,719$42,536,0000.02%
View complete list of EVELO BIOSCIENCES INC shareholders